Novo is building a really big computer
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: drug prices
Contineum Therapeutics files for IPO
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What happens when an approved drug doesn’t work?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Is CAR-T safe for early-stage patients?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Geron’s resurgence might have been short-lived
Want to stay on top of the science and politics driving biotech today? Sign up to get…
When did Wall Street sour on Lilly’s Alzheimer’s drug?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Preventing the weaponization of AI-designed proteins
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Eli Lilly’s anti-vanity ad campaign for Oscars
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biden’s SOTU highlights pharma’s biggest political problem: It is terrifyingly, awfully alone
If you’re a drug company executive, you probably feel like you got up on the…
In his State of the Union, Biden takes clear aim at ‘Big Pharma’
WASHINGTON — Often, a president’s State of the Union address is a staid affair, with…
STAT+: Pharma giants, government spar in court over Medicare drug price negotiation
TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson and Johnson, Novartis, and…
Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a…
.jpg)
Biden to propose expanding Medicare drug price negotiation in State of the Union
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug…
Bayer’s not breaking up. At least not yet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the…
Where’s Lilly’s Alzheimer’s approval?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: White House touts incremental step in Medicare drug price negotiation: counteroffers
WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program…
Serum Institute of India wants government HPV contract
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation
WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case…
Despite good data, Ironwood’s shares plummet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
House looks to weaken Medicare negotiation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…
Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Congress ditches site-neutral hospital pay policy
WASHINGTON — Congress will not move forward with a controversial policy to equalize certain Medicare…
STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional
In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a…
STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription…
What do CEOs owe the world?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Colorado could cap payments for Amgen’s Enbrel
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Actually Wegovy is good for dialysis companies, dialysis provider says
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: How Medicare leaves Puerto Ricans behind
When I accompany my father to his regular cardiologist appointment in Puerto Rico, worry and…
Bayer, short on cash, reaches into shareholders’ pockets
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Obamacare plans don’t have to cover weight loss drugs. The government is considering changing that
WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new…
Alnylam thickened the plot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program
For several years, some of the world’s largest pharmaceutical companies that participate in a U.S….
Pharma’s contractors might finally be on the rebound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: FTC to probe the role of middlemen in worsening drug shortage crisis
The Federal Trade Commission is launching a probe into the extent to which group purchasing…
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
The need to know biotech news stories today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss…
Psychedelic investment continues to ramp up
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Does Moderna’s RSV vaccine lose efficacy faster than others?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more
And so, another working week will soon draw to a close. Not a moment too…
In a showy hearing, Bernie Sanders gets few answers about lower drug prices
WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater. The hearing, featuring Merck…
Gilead sours on the ‘don’t eat me’ business
Want to stay on top of the science and politics driving biotech today? Sign up to get…
New pharma CEOs in the hot seat
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The GLP-1 panic is alive and well
Want to stay on top of the science and politics driving biotech today? Sign up to get…
CDC and social media: The new misinformation war
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Vertex still knows how to do what it does best
Want to stay on top of the science and politics driving biotech today? Sign up to get…